Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

2610005M20Rik Activators

Chemical activators of platelet-activating factor acetylhydrolase, isoform 1b, subunit 2, can modulate the enzyme's function through various mechanisms. Phosphatidylcholine and Lecithin, both containing choline and fatty acids, can be hydrolyzed to produce substrates, such as Lyso-PAF and free choline, that directly bind to the enzyme. This binding enhances the enzyme's acetylhydrolase activity by increasing substrate availability. Additionally, Ginkgolide B engages with the enzyme to promote its active conformation, thereby augmenting its activity. Arachidonic Acid, released from cell membranes, can be metabolized into various bioactive lipids that activate the enzyme by inducing conformational shifts that amplify its catalytic function. Similarly, Platelet-Activating Factor (PAF) itself acts as a substrate for the enzyme, directly triggering its hydrolytic activity upon binding.

In parallel, other molecules can influence intracellular signaling pathways to activate platelet-activating factor acetylhydrolase, isoform 1b, subunit 2. Forskolin and Dibutyryl cAMP, by elevating cAMP levels, activate protein kinase A (PKA), which can then phosphorylate the enzyme, leading to its activation. The same effect can be achieved with 3-Isobutyl-1-methylxanthine (IBMX), which raises cAMP levels by inhibiting phosphodiesterases. Sphingosine-1-phosphate, although not directly interacting with the enzyme, can affect the balance of cellular lipids that regulate the enzyme's activity, thus having an indirect activating effect. The increase in intracellular calcium levels by Calcium Ionophore A23187 can also promote the activation of the enzyme through conformational changes. In cases where specific inhibitors for LPCAT1 are employed, the resulting accumulation of lyso-PAF can activate the enzyme due to increased substrate presence. Each of these activators, whether by direct interaction with the enzyme or modulation of cellular pathways, can lead to an increase in the activity of platelet-activating factor acetylhydrolase, isoform 1b, subunit 2.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ginkgolide B

15291-77-7sc-201037B
sc-201037
sc-201037C
sc-201037A
5 mg
10 mg
25 mg
50 mg
$46.00
$64.00
$114.00
$201.00
8
(1)

Ginkgolide B, a terpenoid from Ginkgo biloba, has been shown to enhance the activity of platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 by binding to the enzyme and promoting its active conformation.

Arachidonic Acid (20:4, n-6)

506-32-1sc-200770
sc-200770A
sc-200770B
100 mg
1 g
25 g
$92.00
$240.00
$4328.00
9
(1)

Arachidonic Acid, upon being released from cell membranes, can be converted into bioactive lipids that can activate platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 by inducing conformational changes that enhance its catalytic activity.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Sphingosine-1-phosphate can activate platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 by influencing sphingolipid metabolism and the balance of cellular lipids that modulate the enzyme's activity.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

Calcium Ionophore A23187 can increase intracellular calcium levels, which can activate platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 by promoting enzyme activity through conformational activation.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

Dibutyryl cAMP, a cell-permeable cAMP analog, can activate PKA, which in turn can phosphorylate and activate platelet-activating factor acetylhydrolase, isoform 1b, subunit 2.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX increases intracellular cAMP by inhibiting phosphodiesterases, which can lead to activation of PKA and subsequent activation of platelet-activating factor acetylhydrolase, isoform 1b, subunit 2.